Cerebral amyloid angiopathy with and without hemorrhage

Neurology

Volumn 84, Issue 12, 2015, Pages 1206-1212

  Charidimou, Andreas ^a,b   Martinez Ramirez, Sergi ^b   Shoamanesh, Ashkan ^b   Oliveira Filho, Jamary ^b   Frosch, Matthew ^c   Vashkevich, Anastasia ^b   Ayres, Alison ^b   Rosand, Jonathan ^b,d,e   Gurol, Mahmut Edip ^b   Greenberg, Steven M ^b   Viswanathan, Anand ^b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b Hemorrhagic Stroke Research Program Stroke Research Center Department of Neurology   (United Kingdom)

^c CS Kubik Laboratory for Neuropathology   (United Kingdom)

^d Division of Neurocritical Care and Emergency Neurology   (United Kingdom)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APOLIPOPROTEIN E EPSILON 2 GENE; APOLIPOPROTEIN E EPSILON 4 GENE; ARTICLE; BRAIN DISEASE; BRAIN HEMORRHAGE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICAL SUPERFICIAL SIDEROSIS; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SENILE PLAQUE; SIDEROSIS; TREND STUDY; VASCULAR AMYLOIDOSIS; BRAIN CORTEX; CLASSIFICATION; GENETICS; HEMOSIDEROSIS; METABOLISM; PATHOLOGY;

APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; BIOLOGICAL MARKER;

AGED; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; BIOMARKERS; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL CORTEX; CEREBRAL HEMORRHAGE; FEMALE; GENOTYPE; HEMOSIDEROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHENOTYPE;

EID: 84925424387     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001398     Document Type: Article

References (38)

1. Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 2012;83:124-137.
2. Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol 2011;70:871-880.
3. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke 1987;18:311-324.
4. Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finklestein SP. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993;43:2073-2079.
5. Ellis RJ, Olichney JM, Thal LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, part XV. Neurology 1996; 46:1592-1596.
6. Linn J, Halpin A, Demaerel P, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 2010;74:1346-1350.
7. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds. A guide to detection and interpretation. Lancet Neurol 2009;8:165-174.
8. Linn J, Wollenweber FA, Lummel N, et al. Superficial siderosis is a warning sign for future intracranial hemorrhage. J Neurol 2013;260:176-181.
9. Charidimou A, Peeters AP, Jager R, et al. Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy. Neurology 2013;81:1666-1673.
10. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:254-259.
11. Greenberg SM, Briggs ME, Hyman BT, et al. Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 1996;27:1333-1337.
12. Rannikmae K, Samarasekera N, Martinez-Gonzalez NA, Al-Shahi Salman R, Sudlow CL. Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2013;84:901-908.
13. Greenberg SM, Vonsattel JP, Segal AZ, et al. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998;50:961-965.
14. Charidimou A, Jager HR. Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? Lancet Neurol 2014;13: 538-540.
15. Brouwers HB, Biffi A, McNamara KA, et al. Apolipoprotein E genotype is associated with CT angiography spot sign in lobar intracerebral hemorrhage. Stroke 2012;43: 2120-2125.
16. Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages. A comparative histological study. Ann Neurol 1991;30:637-649.
17. Greenberg SM, Vonsattel JP. Diagnosis of cerebral amyloid angiopathy: sensitivity and specificity of cortical biopsy. Stroke 1997;28:1418-1422.
18. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822-838.
19. Kidwell CS, Greenberg SM. Red meets white: do microbleeds link hemorrhagic and ischemic cerebrovascular disease? Neurology 2009;73:1614-1615.
20. Charidimou A, Jager RH, Fox Z, et al. Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology 2013;81:626-632.
21. Charidimou A, Jaunmuktane Z, Baron JC, et al. White matter perivascular spaces. An MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology 2014;82:57-62.
22. Doubal FN, MacLullich AM, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke 2010;41:450-454.
23. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356.
24. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453-1457.
25. Zonneveld HI, Goos JD, Wattjes MP, et al. Prevalence of cortical superficial siderosis in a memory clinic population. Neurology 2014;82:698-704.
26. Linn J, Herms J, Dichgans M, et al. Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy. AJNR Am J Neuroradiol 2008;29:184-186.
27. Takeda S, Yamazaki K, Miyakawa T, et al. Subcortical hematoma caused by cerebral amyloid angiopathy: does the first evidence of hemorrhage occur in the subarachnoid space? Neuropathology 2003;23:254-261.
28. Takeda S, Hinokuma K, Yamazaki K, et al. The hemorrhage caused by sporadic-type cerebral amyloid angiopathy occurs primarily in the cerebral sulci. Neuropathology 2012;32:38-43.
29. Nicoll JA, Burnett C, Love S, et al. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997;41:716-721.
30. Shoamanesh A, Martinez-Ramirez S, Oliveira-Filho J, et al. Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy. Neurology 2014; 83:1838-1843.
31. Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 2011;10:241-252.
32. Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM. Progression of cerebral amyloid angiopathy. Accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol 1998;57:353-359.
33. Rannikmae K, Kalaria RN, Greenberg SM, et al. APOE associations with severe CAA-associated vasculopathic changes. Collaborative meta-analysis. J Neurol Neurosurg Psychiatry 2014;85:300-305.
34. Allen N, Robinson AC, Snowden J, Davidson YS, Mann DM. Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease. Neuropathol Appl Neurobiol 2014;40:136-148.
35. Attems J, Jellinger KA, Lintner F. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol 2005;110:222-231.
36. Charidimou A, Peeters A, Fox Z, et al. Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis. Stroke 2012;43:2324-2330.
37. van Etten ES, Auriel E, Haley KE, et al. Incidence of symptomatic hemorrhage in patients with lobar microbleeds. Stroke 2014;45:2280-2285.
38. Xia CF, Arteaga J, Chen G, et al. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. Alzheimers Dement 2013;9:666-676.